Scarica l'app Stockscreener
15.35
1.52%
0.23
Dopo l'orario di chiusura:
15.59
0.24
+1.56%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SDGR Giù?
Forum
Previsione
Precedente Chiudi:
$15.12
Aprire:
$15.02
Volume 24 ore:
879.21K
Relative Volume:
0.67
Capitalizzazione di mercato:
$1.15B
Reddito:
$254.91M
Utile/perdita netta:
$-103.48M
Rapporto P/E:
-10.94
EPS:
-1.4036
Flusso di cassa netto:
$-148.35M
1 W Prestazione:
+1.45%
1M Prestazione:
-5.54%
6M Prestazione:
+9.88%
1 anno Prestazione:
-25.88%
Intervallo 1D:
$14.71
$15.47
Intervallo di 1 settimana:
$14.61
$15.57
Portata 52W:
$10.95
$23.02
Schrodinger Inc Stock (SDGR) Company Profile
Nome
Schrodinger Inc
Settore
Industria
Telefono
503-299-1150
Indirizzo
1540 BROADWAY, NEW YORK, NY
Compare SDGR vs VEEV, BTSG, HQY, TEM, TXG
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SDGR
Schrodinger Inc
|
15.35 | 1.14B | 254.91M | -103.48M | -148.35M | -1.4036 |
VEEV
Veeva Systems Inc
|
201.56 | 31.59B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
72.88 | 14.13B | 13.65B | 169.86M | 412.12M | 1.0758 |
HQY
Healthequity Inc
|
100.99 | 8.28B | 1.34B | 230.70M | 440.96M | 2.6695 |
TEM
Tempus Ai Inc
|
44.29 | 7.73B | 1.36B | -302.91M | -219.93M | -1.7182 |
TXG
10 X Genomics Inc
|
49.43 | 5.83B | 638.78M | -22.66M | 122.18M | -0.1744 |
Schrodinger Inc Stock (SDGR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-15 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2025-09-30 | Iniziato | Goldman | Neutral |
| 2025-08-15 | Downgrade | Citigroup | Buy → Neutral |
| 2025-08-14 | Iniziato | Barclays | Overweight |
| 2025-07-03 | Ripresa | Morgan Stanley | Equal-Weight |
| 2024-07-02 | Iniziato | Leerink Partners | Outperform |
| 2023-12-05 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2023-05-05 | Ripresa | Piper Sandler | Overweight |
| 2022-12-19 | Iniziato | Goldman | Neutral |
| 2022-03-01 | Iniziato | Citigroup | Buy |
| 2021-11-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-19 | Iniziato | Piper Sandler | Overweight |
| 2021-11-11 | Downgrade | BofA Securities | Buy → Neutral |
| 2021-10-13 | Iniziato | Berenberg | Buy |
| 2021-09-01 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2021-05-25 | Iniziato | Craig Hallum | Buy |
| 2020-11-23 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-10-12 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-03-02 | Iniziato | BMO Capital Markets | Outperform |
| 2020-03-02 | Iniziato | Jefferies | Hold |
| 2020-03-02 | Iniziato | Morgan Stanley | Equal-Weight |
Mostra tutto
Schrodinger Inc Borsa (SDGR) Ultime notizie
Rubric Capital Management LP Purchases 1,828,502 Shares of Schrodinger, Inc. $SDGR - MarketBeat
Schrodinger Inc (SDGR) Cash Flow - TradingKey
Schrödinger launches AI co-scientist for drug discovery - Investing.com
Schrödinger Introduces Bunsen, an AI Co-Scientist for Molecular Discovery - Yahoo Finance
Exclusive: Schrödinger CEO 'couldn't be more pleased to be wrong' in launch of AI agent Bunsen - Endpoints News
Schrodinger Inc (SDGR) Valuation: PE, PB & Fair Value Analysis - TradingKey
Schrodinger Inc (SDGR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
AI Stocks: Why Tempus AI (NASDAQ:TEM), Recursion Pharmaceuticals (NASDAQ:RXRX) and Schrodinger (NASDAQ:SDGR) Are in Focus - Kalkine Media
TradingKey - TradingKey
Schrodinger Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
Schrodinger Inc (SDGR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Schrodinger Inc (SDGR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
SDGR|Schrodinger Inc|Price:15.320|Chg%:+0.040 - TradingKey
SDGR|Schrodinger Inc|Price:14.970|Chg%:-0.160 - TradingKey
Schrodinger, Inc. Revenue Breakdown – LS:A2PY7M - TradingView
Schrödinger, Inc. (SDGR) stock price, news, quote and history - Yahoo Finance UK
Schrodinger Inc (SDGR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Enterprise value to revenue forward of Schrodinger, Inc. – NASDAQ:SDGR - TradingView
An AI Biotech Just Reported a 46% Revenue Jump and Its First Recurring Platform Contracts, as Its Pivot Starts Showing Up in the Numbers - marketscreener.com
Schrödinger, Inc. (SDGR) Stock Price, News, Quote & History - Yahoo! Finance Canada
Schrodinger, Inc. (SDGR) Stock Forecasts - Yahoo Finance
Schrödinger to announce Q2 2026 results on August 5 - scanx.trade
Schrödinger to Announce Second Quarter 2026 Financial Results on August 5 - BioSpace
Enterprise value to revenue forward of Schrodinger, Inc. – FWB:43Z - TradingView
Schrodinger, Inc. $SDGR Shares Purchased by Amova Asset Management Americas Inc. - MarketBeat
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)July 20, 2026 - BioSpace
Schrodinger (SDGR) Grants Restricted Stock Units to New Employees - GuruFocus
Schrodinger grants new hires RSUs covering 3,691 shares under inducement plan - Bitget
Schrödinger (SDGR) Jefferies London Healthcare Conference 2025 Summary - Quartr
Schrödinger (SDGR) AGM 2026 Summary - Quartr
Schrödinger (SDGR) Jefferies London Healthcare Conference 2024 Summary - Quartr
Schrodinger CFO Rachit Jain sells $13,647 in stock - Investing.com UK
Schrodinger CFO Rachit Jain sells $13,647 in stock By Investing.com - Investing.com Nigeria
Form 4 Schrodinger Inc For: 17 July By Investing.com - Investing.com Nigeria
Schrodinger (SDGR) CFO sells 875 shares for RSU tax withholding - Stock Titan
Enterprise value to revenue forward of Schrodinger, Inc. – DUS:43Z - TradingView
Form 144 Schrodinger For: 16 July By Investing.com - Investing.com Canada
Hong Kong Stock Market Alert | Simcere Pharmaceutical (02096) Surges Over 6% Intraday Following Global Drug Discovery and Development Collaboration Agreement with U.S.-based Schrödinger, Inc. - 富途牛牛
Price to book forward of Schrodinger, Inc. – NASDAQ:SDGR - TradingView
Price to earnings forward of Schrodinger, Inc. – BOATS:SDGR - TradingView
BMO Capital Remains a Buy on Schrodinger (SDGR) - The Globe and Mail
Enterprise value to EBITDA forward of Schrodinger, Inc. – NASDAQ:SDGR - TradingView
Generative AI in Drug Discovery: Revolutionizing Pharmaceutical Research and Development - GlobeNewswire Inc.
Price to sales forward of Schrodinger, Inc. – NASDAQ:SDGR - TradingView
(SDGR) Volatility Zones as Tactical Triggers - Stock Traders Daily
Schrodinger Inc. (SDGR) Jumps 3.73% as Software-Driven Drug Discovery Gains TractionGap and Reverse - dars.gov.et
Schrödinger: Surviving, If Not Thriving, In The Tricky AI Drug Discovery Field (SDGR) - Seeking Alpha
Schrodinger explores computational chemistry. Nasdaq biotech stock leans on its platform - AD HOC NEWS
Citigroup Downgrades Schrödinger (SDGR) - MSN
SDGRSchrodinger Inc Latest SEC Filings - Finviz
Jain Rachit, Schrodinger CFO, sells $21k in SDGR stock By Investing.com - Investing.com Nigeria
Schrodinger Inc Azioni (SDGR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.08%
0.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):